Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome (Q36600970)

15 August 2017

1 reference

title

Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome (English)

1 reference

15 August 2017

0 references

David J Riedel

1

1 reference

15 August 2017

Carlos A Pardo

series ordinal

2

1 reference

15 August 2017

Justin McArthur

series ordinal

3

1 reference

15 August 2017

Avindra Nath

series ordinal

4

1 reference

15 August 2017

1 October 2006

1 reference

Nature Clinical Practice Neurology

15 August 2017

1 reference

15 August 2017

2

1 reference

15 August 2017

10

1 reference

15 August 2017

557-565

1 reference

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

15 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Changing incidence of central nervous system diseases in the EuroSIDA cohort

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Immune Reconstitution Syndrome in HIV: Validating a Case Definition and Identifying Clinical Predictors in Persons Initiating Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Immune reconstitution inflammatory syndrome: more answers, more questions

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Immune restoration with antiretroviral therapies: implications for clinical management

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Granzyme B mediates neurotoxicity through a G-protein-coupled receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Immune restoration disease after antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Military tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Cerebral mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated mycobacterium avium complex infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

HIV combination therapy: immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Relapsing meningitis caused by persistent cryptococcal antigens and immune reconstitution after the initiation of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Raised intracranial pressure complicating cryptococcal meningitis: immune reconstitution inflammatory syndrome or recurrent cryptococcal disease?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Paradoxical intracranial cryptococcoma in a human immunodeficiency virus-infected man being treated with combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Multiple cerebral cryptococcomas associated with immune reconstitution in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Progressive multifocal leukoencephalopathy after initiation of highly active antiretroviral therapy in a child with advanced human immunodeficiency virus infection: a case of immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Evolution of purely infratentorial PML under HAART--negative outcome under rapid immune reconstitution.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Enhancing progressive multifocal leukoencephalopathy: an indicator of improved immune status?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Progressive multifocal leucoencephalopathy with unusual inflammatory response during antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Inflammatory Reaction in Progressive Multifocal Leukoencephalopathy: Harmful or Beneficial?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

HIV-associated retinopathy in the HAART era.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Treatment of immune recovery vitritis with local steroids

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Immune reconstitution inflammatory syndrome in HIV.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Placebo-controlled trial of prednisone in advanced HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0303

7 January 2021

Identifiers

DOI

10.1038/NCPNEURO0303

1 reference

15 August 2017

1 reference